CFDE Data Portal | Search STRIT1

	Label	Description
	STRIT1 Gene (Entity type)	ENSG00000240045 - small transmembrane regulator of ion transport 1
	GSE242555 1 V 0 NICOTINAMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE189035 inositol 2 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE173116 GSE173118 ML-7 3 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE119978 GSE180930 cisplatin 6 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE236228 penfluridol 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE199862 Chk1 inhibition 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE173116 GSE173118 ML-7 1 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE119978,GSE180930 2 V 7 CISPLATIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE119978 GSE180930 cisplatin 6 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS

STRIT1

ENSG00000240045 - small transmembrane regulator of ion transport 1

GSE242555 1 V 0 NICOTINAMIDE HUMAN DN

A Gene Set from LINCS

GSE189035 inositol 2 v 4 human dn

A Gene Set from LINCS

GSE173116 GSE173118 ML-7 3 v 5 human up

A Gene Set from LINCS

GSE119978 GSE180930 cisplatin 6 v 7 human dn

A Gene Set from LINCS

GSE236228 penfluridol 0 v 1 human up

A Gene Set from LINCS

GSE199862 Chk1 inhibition 3 v 1 human dn

A Gene Set from LINCS

GSE173116 GSE173118 ML-7 1 v 5 human up

A Gene Set from LINCS

GSE119978,GSE180930 2 V 7 CISPLATIN HUMAN DN

A Gene Set from LINCS

GSE119978 GSE180930 cisplatin 6 v 1 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.